Terramycin has been used orally for the treatment of gonorrhoea by a number of workers, including Caldwell and others (1950), Robinson (1950, 1952), Sayer and others (1951), and Schoch and Alexander (1950). In general, the results obtained by single doses of 0-5-1 0 g. have not been entirely satisfactory. Putkonen (1951) , for example, cured only 45 out of 55 patients with 1-0 g., and the administration of two doses of 0 5-1 0 g. each at an interval of 6 hours has been reported to give better results. Thus Wright and others (1951) had 88-7 per cent. of 120 patients cured by two doses of 0 5 g., and Hendricks and others (1950) claimed that all of a group of fifteen were cured by two doses of 1-0 g. A comparison of terramycin and aureomycin, in doses of 1-02-0 g., was attempted by Beinfield and others (1951). Of 130 patients treated with terramycin, 106 were followed-up and there were five relapses. Of 130 others treated with aureomycin, 107 were followed-up and there were four relapses.
Present Investigations
The trials with terramycin reported here have been in progress since November, 1950 . Several schedules involving a total dose of 2-0 g. given orally have been tried:
(1) 1 g. given at once, followed by a further dose of I g. after 6 hrs (Willcox, 1951) .
(2) One capsule (250 mg.) given four times a day for 2 days (Willcox, 1952) .
(3) Two capsules (500 mg.) given four times a day for one day (Willcox, 1953a) . (4) 1 g. given at once, followed by one capsule (250 mg.) four times a day for one day (Willcox, 1953b) .
(5) A single oral dose of 2 g. (Willcox, 1953c) .
The-numbers previously reported have been added to and a total of 202 cases is now presented.
* Received for publication March 23, 1953. The results of treatment are compared with those in 223 cases of gonorrhoea treated during the same period with single injections of 150,000 units procaine penicillin. Basic details of the two groups are given in Table I . In fact, however, nearly all of the failures noted after one month were believed to be re-infections on the criterion of admitted new intercourse with a person who, on being secured for examination, was found to be suffering from gonorrhoea. In Table  III , in which by cumulating the failure rate some allowance is made for the differences in follow-up, the suspected relapses have been differentiated from the re-infections.
Thus, although the ultimate results of treatment with terramycin are apparently as good as those of penicillin in the dosage given, there were more failures with terramycin in the days immediately following treatment than with penicillin. It is likely, therefore, that most of the 'relapses ' with penicillin after 28 days were also re-infections. As it stands the results of treatment at one month were in favour of penicillin, and at 3 months in favour of terramycin.
A A comparison of the terramycin schedules is shown in Table IV .
Schedule IV (1 g. followed by one capsule (250 mg.) four times a day for one day) proved to be the best of those tested, while Schedules I and V were the least successful.
Non-Specific Urethritis
Of particular interest is the comparison of the incidence of non-specific infections (Table V, opposite). Penicillin, unlike terramycin (Willcox and Findlay, 1952) , is not usually effective in the treatment of non-specific urethritis. Thus, if non-specific urethritis has an infective aetiology, one might expect that it would be aborted during the terramycin treatment of gonorrhoea.
It is possible that some of the re-treatments for non-specific urethritis made during the first week Of the nineteen cases of non-specific infections noted in the terramycin-treated series, sixteen had uncomplicated urethritis, two had persistent pus in the prostatic smears, and in one the urethritis was complicated by Reiter's syndrome (at 26 days). Of the 35 cases in the penicillin-treated series, 31 had uncomplicated urethritis, one was complicated by cystitis, one by Reiter's syndrome (at 10 days), and in two cases there was persistent pus in the prostatic smear. Thus neither penicillin nor terramycin prevented the development of Reiter's syndrome.
The incidence of non-specific urethritis following the different terramycin schedules is shown in Table VI (2) The results of the two methods were comparable, whether suspected re-infections were included as " failures " or not.
(3) The most successful terramycin schedule was that consisting of 1 g. given immediately and followed by 250 mg. four times in one day. There was only one gonococcus-positive failure in 37 cases followed out of 45 patients treated.
(4) The incidence of subsequent non-specific urethritis was also compared.
No significant difference was noted between the terramycin-treated and the penicillin-treated groups. Terramycin, in the dosage given, was no more successful than penicillin in preventing non-specific urethritis or Reiter's syndrome.
(5) The terramycin schedule which was followed by the least non-specific urethritis was that consisting of 2 g. in a single oral dose (only one case in 29 followed out of 37 treated). As this schedule was likely to have produced the highest, if transient, terramycin serum levels, it is considered that it will be worth while to continue this part of the investigation employing a higher dosage.
The terramycin used in this study was 
